Dingdang Health Technology Group Ltd. (the “Company,” stock code: 09886) announced, effective February 16, 2026, that Mr. Yu Lei has resigned from the roles of executive Director, vice president, and all other positions within the Group, citing personal career development plans. According to the announcement, Mr. Yu confirmed no disagreement with the Board and no other matters needing to be brought to the attention of the Company’s shareholders or the Hong Kong Stock Exchange.

In conjunction, the Company appointed Mr. Meng Fanzhou, aged 43, as an executive Director and vice president with effect from the same date. Mr. Meng joined the Group in August 2015 and has served as vice president of Dingdang Medicine Express Technology, overseeing its daily operations. He previously worked as operation director of Lefeng.com (Shanghai) from April 2013 to February 2015 and obtained a college diploma in economics (project management) through online education from Beihang University in July 2013.

Under the terms of Mr. Meng’s service contract, the initial three-year term commences on February 16, 2026, and may be renewed automatically for successive three-year terms, subject to termination by either party with at least three months’ prior written notice. He will hold office until the first annual general meeting of the Company after his appointment and be eligible for re-election in accordance with the Company’s articles of association. He does not receive director’s fees in addition to remuneration for other positions within the Group.

According to the announcement, Mr. Meng is interested in an aggregate of 2.30 million shares of the Company, representing 2.00 million restricted shares granted under the Restricted Share Scheme adopted on May 1, 2020, and 0.30 million restricted share units granted under the 2023 Restricted Share Unit Scheme adopted on June 27, 2023. He has no other directorships in listed companies over the past three years and no relationships with any Director, senior management, substantial shareholder, or controlling shareholder of the Company.

As of the date of the announcement, the executive Directors are Mr. Yang Wenlong, Mr. Yang Yibin, Mr. Xu Ning, Mr. Yu Qinglong, and Mr. Meng Fanzhou. The non-executive Director is Ms. Li Chuheng, and the independent non-executive Directors are Mr. Zhang Shouchuan, Dr. Fan Zhenhong, and Mr. Jiang Shan.